Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China
Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China. The Boston-based biotech has focused on developing T ...
ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · CN
- [HEALTH] Who writes the pandemic? State power, individual subjectivity, and the history of the present in China's COVID-19 respon
- [DIPLOMACY] China takes helm of UN Security Council, vows unity and cooperation
- [TECH] 2026.18: Long-term, Peripheral & Myopic Visions
- [CONFLICT] The Chinese Government Just Got the World’s Largest Digital Rights Conference Canceled
- [CONFLICT] The Chinese Government Just Got the World’s Largest Digital Rights Conference Canceled
- [DIPLOMACY] LIVE: China takes over UN Security Council presidency for May